An Sp1 binding site involves the transcription of the Fas ligand gene induced by PMA and ionomycin in Jurkat cells

被引:8
作者
Chou, CF
Peng, HW
Wang, CY
Yang, YT
Han, SH
机构
[1] Cheng Hsin Gen Hosp, Taipei, Taiwan
[2] Natl Yang Ming Univ, Immunol Res Ctr, Tao Yuan, Taiwan
[3] Natl Yang Ming Univ, Inst Microbiol & Immunol, Tao Yuan, Taiwan
[4] Armed Forces Taoyuan Gen Hosp, Dept Med, Tao Yuan, Taiwan
[5] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan
关键词
Fas ligand; transcription; Sp1 binding site;
D O I
10.1007/BF02256620
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The transcriptional regulation of the Fas ligand (FasL) gene in Jurkat cells was investigated. We demonstrated that an Sp1 binding site, located between -280 and -275 bp relative to the translational start site (+1) of the Fast gene, was important for the transcription of the Fast gene by deletion and mutation analysis in Jurkat cells after phorbol 12-myristate 13-acetate (PMA) and ionomycin treatment. Nuclear extract of Jurkat cells formed complexes with the oligonucleotides bearing the Spl site within -280 to -275 of the Fast promoter. Apart from the constitutive complexes, a new complex was observed after PMA and ionomycin stimulation. Plasmid containing the Sp1 site sequence with site-directed mutation reduced the Fast promoter activity in driving the expression of reporter luciferase gene expression in transfected Jurkat cells after PMA and ionomycin stimulation. The binding of activated Jurkat cell nuclear extract to the mutated Spl binding site of the Fast promoter was ablated. In addition, the oligomer containing the Spl site of the Fast promoter could compete with oligomer with conserved Spl binding sequence in nuclear protein binding of activated Jurkat cells. The data presented in this study suggest that the transactivation of the Fast promoter via the Spl binding sequence (-280 to -275) involves the PMA- and ionomycin-induced expression of the Fast gene. Copyright (C) 2000 National Science Council, ROC and S. Karger AG, Basel.
引用
收藏
页码:136 / 143
页数:8
相关论文
共 36 条
[21]   THE FAS DEATH FACTOR [J].
NAGATA, S ;
GOLSTEIN, P .
SCIENCE, 1995, 267 (5203) :1449-1456
[22]  
Norian LA, 1998, J IMMUNOL, V161, P1078
[23]   ROLE OF APOPTOSIS IN HIV DISEASE PATHOGENESIS [J].
OYAIZU, N ;
PAHWA, S .
JOURNAL OF CLINICAL IMMUNOLOGY, 1995, 15 (05) :217-231
[24]   Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C ζ [J].
Pal, S ;
Claffey, P ;
Cohen, HT ;
Mukhopadhyay, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (41) :26277-26280
[25]   A COOPERATIVE INTERACTION BETWEEN NF-KAPPA-B AND SP1 IS REQUIRED FOR HIV-1 ENHANCER ACTIVATION [J].
PERKINS, ND ;
EDWARDS, NL ;
DUCKETT, CS ;
AGRANOFF, AB ;
SCHMID, RM ;
NABEL, GJ .
EMBO JOURNAL, 1993, 12 (09) :3551-3558
[26]   Activation of Sp1 and its functional co-operation with serum amyloid a-activating sequence binding factor in synoviocyte cells trigger synergistic action of interleukin-1 and interleukin-6 in serum amyloid A gene expression [J].
Ray, A ;
Schatten, H ;
Ray, BK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (07) :4300-4308
[27]   MUTATIONS IN FAS ASSOCIATED WITH HUMAN LYMPHOPROLIFERATIVE SYNDROME AND AUTOIMMUNITY [J].
RIEUXLAUCAT, F ;
LEDEIST, F ;
HIVROZ, C ;
ROBERTS, IAG ;
DEBATIN, KM ;
FISCHER, A ;
DEVILLARTAY, JP .
SCIENCE, 1995, 268 (5215) :1347-1349
[28]   Involvement of NF-AT in type I human T-cell leukemia virus tax-mediated Fas ligand promoter transactivation [J].
Rivera, I ;
Harhaj, EW ;
Sun, SC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (35) :22382-22388
[29]   Fas ligand expression by astrocytoma in vivo: Maintaining immune privilege in the brain? [J].
Saas, P ;
Walker, PR ;
Hahne, M ;
Quiquerez, AL ;
Schnuriger, V ;
Perrin, G ;
French, L ;
Van Meir, EG ;
deTribolet, N ;
Tschopp, J ;
Dietrich, PY .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06) :1173-1178
[30]   Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1 [J].
Srivastava, S ;
Weitzmann, MN ;
Kimble, RB ;
Rizzo, M ;
Zahner, M ;
Milbrandt, J ;
Ross, FP ;
Pacifici, R .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (10) :1850-1859